BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 32024383)

  • 1. Truncated Bid Regulates Cisplatin Response via Activation of Mitochondrial Apoptosis Pathway in Ovarian Cancer.
    Dai Y; Zhao XJ; Li F; Yuan Y; Yan DM; Cao H; Huang XY; Hu Z; Ma D; Gao QL
    Hum Gene Ther; 2020 Mar; 31(5-6):325-338. PubMed ID: 32024383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenovirus-mediated truncated Bid overexpression induced by the Cre/LoxP system promotes the cell apoptosis of CD133+ ovarian cancer stem cells.
    Long Q; Yang R; Lu W; Zhu W; Zhou J; Zheng C; Zhou D; Yu L; Wu J
    Oncol Rep; 2017 Jan; 37(1):155-162. PubMed ID: 27878291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Truncated Bid Overexpression Induced by Recombinant Adenovirus Cre/LoxP System Suppresses the Tumorigenic Potential of CD133
    Long Q; Zhu W; Zhou J; Wu J; Lu W; Zheng C; Zhou D; Yu L; Yang R
    Oncol Res; 2017 Apr; 25(4):595-603. PubMed ID: 27760587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A potent oncolytic adenovirus selectively blocks the STAT3 signaling pathway and potentiates cisplatin antitumor activity in ovarian cancer.
    Han Z; Hong Z; Gao Q; Chen C; Hao Z; Ji T; Hu W; Yan Y; Feng J; Liao S; Wu P; Wang D; Wang S; Zhou J; Ma D
    Hum Gene Ther; 2012 Jan; 23(1):32-45. PubMed ID: 21875334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanistic issues of the interaction of the hairpin-forming domain of tBid with mitochondrial cardiolipin.
    Gonzalvez F; Pariselli F; Jalmar O; Dupaigne P; Sureau F; Dellinger M; Hendrickson EA; Bernard S; Petit PX
    PLoS One; 2010 Feb; 5(2):e9342. PubMed ID: 20179769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenoviral Bid overexpression induces caspase-dependent cleavage of truncated Bid and p53-independent apoptosis in human non-small cell lung cancers.
    Fukazawa T; Walter B; Owen-Schaub LB
    J Biol Chem; 2003 Jul; 278(28):25428-34. PubMed ID: 12690107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenovirus-mediated tBid overexpression results in therapeutic effects on p53-resistant hepatocellular carcinoma.
    Miao J; Chen GG; Chun SY; Yun JP; Chak EC; Ho RL; Lai PB
    Int J Cancer; 2006 Oct; 119(8):1985-93. PubMed ID: 16708390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular basis of the interaction between proapoptotic truncated BID (tBID) protein and mitochondrial carrier homologue 2 (MTCH2) protein: key players in mitochondrial death pathway.
    Katz C; Zaltsman-Amir Y; Mostizky Y; Kollet N; Gross A; Friedler A
    J Biol Chem; 2012 Apr; 287(18):15016-23. PubMed ID: 22416135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bax/Bak activation in the absence of Bid, Bim, Puma, and p53.
    Zhang J; Huang K; O'Neill KL; Pang X; Luo X
    Cell Death Dis; 2016 Jun; 7(6):e2266. PubMed ID: 27310874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct lipid effects on tBid and Bim activation of membrane permeabilization by pro-apoptotic Bax.
    Shamas-Din A; Bindner S; Chi X; Leber B; Andrews DW; Fradin C
    Biochem J; 2015 May; 467(3):495-505. PubMed ID: 25714678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced antitumor activity by combining an adenovirus harboring ING4 with cisplatin for hepatocarcinoma cells.
    Xie Y; Sheng W; Miao J; Xiang J; Yang J
    Cancer Gene Ther; 2011 Mar; 18(3):176-88. PubMed ID: 21052098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of Apoptosis by the Nonstructural Protein 4 and 10 of Porcine Reproductive and Respiratory Syndrome Virus.
    Yuan S; Zhang N; Xu L; Zhou L; Ge X; Guo X; Yang H
    PLoS One; 2016; 11(6):e0156518. PubMed ID: 27310256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-regulatable cancer cell death induced by BID under control of the tissue-specific, lung cancer-targeted TTS promoter system.
    Fukazawa T; Maeda Y; Matsuoka J; Tanaka N; Tanaka H; Durbin ML; Naomoto Y
    Int J Cancer; 2009 Oct; 125(8):1975-84. PubMed ID: 19598260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitization of tumor cells to Apo2 ligand/TRAIL-induced apoptosis by inhibition of casein kinase II.
    Ravi R; Bedi A
    Cancer Res; 2002 Aug; 62(15):4180-5. PubMed ID: 12154014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective cytotoxicity to HER2-positive tumor cells by a recombinant e23sFv-TD-tBID protein containing a furin cleavage sequence.
    Wang F; Ren J; Qiu XC; Wang LF; Zhu Q; Zhang YQ; Huan Y; Meng YL; Yao LB; Chen SY; Xu YM; Yang AG
    Clin Cancer Res; 2010 Apr; 16(8):2284-94. PubMed ID: 20371697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MTCH2/MIMP is a major facilitator of tBID recruitment to mitochondria.
    Zaltsman Y; Shachnai L; Yivgi-Ohana N; Schwarz M; Maryanovich M; Houtkooper RH; Vaz FM; De Leonardis F; Fiermonte G; Palmieri F; Gillissen B; Daniel PT; Jimenez E; Walsh S; Koehler CM; Roy SS; Walter L; Hajnóczky G; Gross A
    Nat Cell Biol; 2010 Jun; 12(6):553-562. PubMed ID: 20436477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cleavage by Caspase 8 and Mitochondrial Membrane Association Activate the BH3-only Protein Bid during TRAIL-induced Apoptosis.
    Huang K; Zhang J; O'Neill KL; Gurumurthy CB; Quadros RM; Tu Y; Luo X
    J Biol Chem; 2016 May; 291(22):11843-51. PubMed ID: 27053107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real time single cell analysis of Bid cleavage and Bid translocation during caspase-dependent and neuronal caspase-independent apoptosis.
    Ward MW; Rehm M; Duessmann H; Kacmar S; Concannon CG; Prehn JH
    J Biol Chem; 2006 Mar; 281(9):5837-44. PubMed ID: 16407197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of bladder cancer-specific oncolytic adenovirus gene therapy with cisplatin on bladder cancer in vitro.
    Wang L; Zhang Y; Zhao J; Xiao E; Lu J; Fu S; Wang Z
    Tumour Biol; 2014 Nov; 35(11):10879-90. PubMed ID: 25085582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-chain antibody/activated BID chimeric protein effectively suppresses HER2-positive tumor growth.
    Qiu XC; Xu YM; Wang F; Fan QY; Wang LF; Ma BA; Jia LT; Zhao J; Meng YL; Yao LB; Chen SY; Yang AG
    Mol Cancer Ther; 2008 Jul; 7(7):1890-9. PubMed ID: 18644999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.